Research and Development Costs of New Drugs-Reply

Affiliations

¹ Department of Health Policy, London School of Economics and Political Science, London, United Kingdom.
² Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom.
³ Department of Public Health and Primary Care, Leuven Institute for Healthcare Policy, Leuven, Belgium.

Comment

Olivier J Wouters et al. JAMA. 2020.

. 2020 Aug 4;324(5):518.

doi: 10.1001/jama.2020.8651.

¹ Department of Health Policy, London School of Economics and Political Science, London, United Kingdom.
² Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom.
³ Department of Public Health and Primary Care, Leuven Institute for Healthcare Policy, Leuven, Belgium.

Erratum in

Error in Data in Study of Estimated Cost of Bringing a Drug to Market.
[No authors listed] [No authors listed] JAMA. 2022 Sep 20;328(11):1111. doi: 10.1001/jama.2022.14733. JAMA. 2022. PMID: 36125490 Free PMC article. No abstract available.

No abstract available

Research and Development Costs of New Drugs.
Dierynck B, Joos P. Dierynck B, et al. JAMA. 2020 Aug 4;324(5):516-517. doi: 10.1001/jama.2020.8642. JAMA. 2020. PMID: 32749483 No abstract available.
Research and Development Costs of New Drugs.
Dominguez LW, Willis JS. Dominguez LW, et al. JAMA. 2020 Aug 4;324(5):516. doi: 10.1001/jama.2020.8645. JAMA. 2020. PMID: 32749484 No abstract available.
Research and Development Costs of New Drugs.
DiMasi JA. DiMasi JA. JAMA. 2020 Aug 4;324(5):517. doi: 10.1001/jama.2020.8648. JAMA. 2020. PMID: 32749485 No abstract available.